Alliancebernstein L.P. Medicinova Inc Transaction History

Alliancebernstein L.P.

9 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2021 Jul 30, 2021	SELL	$3.76 - $5.14 $117,688 - $160,882	-31,300 Closed	0 $0
Q4 2020 Feb 08, 2021	SELL	$5.03 - $6.31 $27,665 - $34,705	-5,500 Reduced 14.95%	31,300 $165,000
Q2 2020 Aug 13, 2020	BUY	$3.06 - $7.06 $23,562 - $54,362	7,700 Added 26.46%	36,800 $199,000
Q1 2020 May 14, 2020	BUY	$2.9 - $6.97 $5,510 - $13,243	1,900 Added 6.99%	29,100 $108,000
Q3 2019 Nov 14, 2019	BUY	$7.7 - $10.42 $35,420 - $47,932	4,600 Added 20.35%	27,200 $216,000
Q2 2019 Aug 14, 2019	BUY	$8.29 - $13.22 $26,527 - $42,304	3,200 Added 16.49%	22,600 $218,000
Q1 2019 May 14, 2019	BUY	$6.82 - $10.27 $31,372 - $47,242	4,600 Added 31.08%	19,400 $161,000
Q4 2018 Feb 13, 2019	BUY	$7.65 - $12.83 $32,130 - $53,886	4,200 Added 39.62%	14,800 $121,000
Q3 2018 Nov 08, 2018	BUY	$7.06 - $12.49 $74,836 - $132,394	10,600 New	10,600 $132,000

5.13M

Ticker MNOV
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 49,046,200
Market Cap $72.6M
Description
MediciNova, Inc., a biopharmaceutical company, focuses on developing novel and small molecule therapeutics for the treatment of serious diseases with unmet medical needs in the United States. The company is developing MN-166 (ibudilast), an oral anti-inflammatory and neuroprotective agent for treating neurological disorders, such as primary and ...

Get notified when there are updates to the investment portfolio of Alliancebernstein L.P., based on Form 13F filings with the SEC.

Stay updated on Alliancebernstein L.P. with notifications on news.